Ignite Creation Date:
2024-07-17 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06485752
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-27
Brief Title:
Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine
Sponsor:
Novavax
Organization:
Novavax
Conditions & Keywords Data
Conditions:
| Name |
|---|
| COVID-19 |
Keywords:
| Name | View |
|---|---|
| COVID-19 influenza Vaccine | View |